Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

[Management of macular edema secondary to retinal vein occlusion].

Girmens JF, Glacet-Bernard A, Kodjikian L, Nghiêm-Buffet S, Massé H, Fourmaux E, Wolff B, Roquet W, Gaucher D, Baillif S, Tadayoni R.

J Fr Ophtalmol. 2015 Mar;38(3):253-63. doi: 10.1016/j.jfo.2014.10.003. Epub 2015 Feb 13. Review. French.

2.
3.

Intravitreal ranibizumab and/or dexamethasone implant for macular edema secondary to retinal vein occlusion.

Nghiem-Buffet S, Fajnkuchen F, Buffet M, Ayrault S, Le Gloahec-Lorcy A, Grenet T, Delahaye-Mazza C, Quentel G, Cohen SY.

Ophthalmologica. 2014;232(4):216-22. doi: 10.1159/000365639. Epub 2014 Nov 19.

PMID:
25413000
4.

Retinal oximetry during treatment of retinal vein occlusion by ranibizumab in patients with high blood pressure and dyslipidemia.

Keilani C, Halalchi A, Wakpi Djeugue D, Regis A, Abada S.

J Fr Ophtalmol. 2016 Dec;39(10):816-821. doi: 10.1016/j.jfo.2016.08.007. Epub 2016 Nov 16.

5.

Management of macular edema secondary to branch retinal vein occlusion: an evidence-based update.

Aref AA, Scott IU.

Adv Ther. 2011 Jan;28(1):28-39. doi: 10.1007/s12325-010-0089-3. Epub 2010 Dec 9. Review.

PMID:
21153509
6.

Management of macular edema secondary to central retinal vein occlusion: an evidence-based.

Aref AA, Scott IU.

Adv Ther. 2011 Jan;28(1):40-50. doi: 10.1007/s12325-010-0088-4. Epub 2010 Dec 9. Review.

PMID:
21153510
7.

Efficacy and Safety of Dexamethasone Intravitreal Implant for Treatment of Refractory Macular Edema Secondary to Retinal Vein Occlusion in Taiwan.

Sheu SJ, Wu TT, Horng YH.

J Ocul Pharmacol Ther. 2015 Oct;31(8):461-7. doi: 10.1089/jop.2014.0119. Epub 2015 Jun 11.

PMID:
26067779
8.

Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.

Mayer WJ, Remy M, Wolf A, Kook D, Kampik A, Ulbig M, Reznicek L, Haritoglou C.

Ophthalmologica. 2012;228(2):110-6. doi: 10.1159/000338732. Epub 2012 Jun 23.

PMID:
22739239
9.

[Morphologic Patterns on Spectral-Domain Optical Coherence Tomography (SD-OCT) as a Prognostic Indicator in Treatment of Macular Edema Due to Retinal Vein Occlusion].

Groneberg T, Trattnig JS, Feucht N, Lohmann CP, Maier M.

Klin Monbl Augenheilkd. 2016 Sep;233(9):1056-62. doi: 10.1055/s-0041-108680. Epub 2016 Feb 8. German.

PMID:
26854482
10.

Reading speed improvements in retinal vein occlusion after ranibizumab treatment.

Suñer IJ, Bressler NM, Varma R, Lee P, Dolan CM, Ward J, Colman S, Rubio RG.

JAMA Ophthalmol. 2013 Jul;131(7):851-6. doi: 10.1001/jamaophthalmol.2013.114.

PMID:
23699977
11.

Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group.

Ophthalmology. 2010 Jun;117(6):1134-1146.e3. doi: 10.1016/j.ophtha.2010.03.032. Epub 2010 Apr 24.

PMID:
20417567
12.

Intravitreal ranibizumab for macular edema secondary to retinal vein occlusion.

Kim M, Yu SY, Kim ES, Bae SH, Park JH, Yu HG, Kwak HW.

Ophthalmologica. 2012;227(3):132-8. doi: 10.1159/000334906. Epub 2011 Dec 29.

PMID:
22212151
13.

Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review.

Glanville J, Patterson J, McCool R, Ferreira A, Gairy K, Pearce I.

BMC Ophthalmol. 2014 Jan 21;14:7. doi: 10.1186/1471-2415-14-7. Review.

14.

Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant.

Yeh WS, Haller JA, Lanzetta P, Kuppermann BD, Wong TY, Mitchell P, Whitcup SM, Kowalski JW.

Ophthalmology. 2012 Jun;119(6):1190-8. doi: 10.1016/j.ophtha.2011.12.028. Epub 2012 Feb 22.

PMID:
22361318
15.

[Retinal vein occlusions].

Pierru A, Girmens JF, Héron E, Paques M.

J Fr Ophtalmol. 2017 Oct;40(8):696-705. doi: 10.1016/j.jfo.2017.04.003. Epub 2017 Sep 13. Review. French.

PMID:
28916115
16.

Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion.

Tan MH, McAllister IL, Gillies ME, Verma N, Banerjee G, Smithies LA, Wong WL, Wong TY.

Am J Ophthalmol. 2014 Jan;157(1):237-247.e1. doi: 10.1016/j.ajo.2013.08.013. Epub 2013 Oct 7.

PMID:
24112635
17.

[Efficacy of intravitreal dexamethasone implants in macular edema excluding venous occlusions: results for a cohort of 80 patients].

Degoumois A, Akesbi J, Laurens C, Rodallec FT, Adam R, Blumen-Ohana E, Laplace O, Virevialle C, Le Dû B, Guyader V, Nordmann JP.

J Fr Ophtalmol. 2015 Feb;38(2):126-33. doi: 10.1016/j.jfo.2014.08.003. Epub 2015 Jan 13. French.

18.

Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting.

Ferrini W, Ambresin A.

Klin Monbl Augenheilkd. 2013 Apr;230(4):423-6. doi: 10.1055/s-0032-1328388. Epub 2013 Apr 29.

PMID:
23629796
19.

Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.

Heier JS, Campochiaro PA, Yau L, Li Z, Saroj N, Rubio RG, Lai P.

Ophthalmology. 2012 Apr;119(4):802-9. doi: 10.1016/j.ophtha.2011.12.005. Epub 2012 Feb 1.

PMID:
22301066
20.

Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.

Puche N, Glacet A, Mimoun G, Zourdani A, Coscas G, Soubrane G.

Acta Ophthalmol. 2012 Jun;90(4):357-61. doi: 10.1111/j.1755-3768.2010.01913.x. Epub 2010 Jun 29.

Supplemental Content

Support Center